Compare FCEL & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FCEL | IRMD |
|---|---|---|
| Founded | 1969 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2005 | 2014 |
| Metric | FCEL | IRMD |
|---|---|---|
| Price | $19.34 | $87.40 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $8.31 | ★ $116.00 |
| AVG Volume (30 Days) | ★ 8.5M | 110.0K |
| Earning Date | 06-05-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 0.95% |
| EPS Growth | 5.24 | ★ 16.67 |
| EPS | N/A | ★ 0.86 |
| Revenue | ★ $89,437,000.00 | $83,814,000.00 |
| Revenue This Year | $4.77 | $12.38 |
| Revenue Next Year | $42.46 | $11.31 |
| P/E Ratio | ★ N/A | $100.79 |
| Revenue Growth | N/A | ★ 14.43 |
| 52 Week Low | $3.81 | $67.84 |
| 52 Week High | $37.88 | $107.90 |
| Indicator | FCEL | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 46.21 | 38.07 |
| Support Level | $17.33 | $83.58 |
| Resistance Level | $26.16 | $87.99 |
| Average True Range (ATR) | 2.28 | 2.51 |
| MACD | -0.14 | -0.29 |
| Stochastic Oscillator | 22.83 | 22.92 |
FuelCell Energy Inc is a clean energy technology company engaged in the development, design, production, and servicing of high temperature fuel cells for clean electric power generation. The Company provides proprietary molten carbonate fuel cell systems that generate electricity electrochemically with ultra low emissions and high efficiency, and operates as a solutions provider managing the design, manufacturing, installation, and maintenance of its systems under long term power purchase, service, and engineering procurement agreements. The Company serves utilities, data centers, and commercial and industrial customers, and operates in the United States, South Korea, Europe, and Canada, with maximum revenue generated from the United States.
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.